非流感呼吸道病毒所致社区获得性肺炎的疾病严重程度与临床结局:CAP-China网络多中心前瞻性登记研究
该研究在中国大陆34家医院前瞻性纳入住院的免疫功能正常的社区获得性肺炎(CAP)成年患者,通过分子方法检测呼吸道病毒,比较流感与非流感病毒感染组。共分析915例病毒感染患者,非流感病毒占病毒性肺炎27.4%。非流感病毒感染的并发症发生率及疾病严重程度与流感病毒相似,提示应更关注非流感呼吸道病毒所致CAP。
要点
- 非流感呼吸道病毒占病毒性肺炎27.4%,流感病毒最常见(28.4%)。
- 非流感病毒感染的脓毒症和低氧血症发生率与流感病毒组无显著差异。
- 非流感病毒 vs 流感病毒的90天死亡风险比为0.51(95%CI 0.13-1.91)。
核心结论
- 非流感病毒所致CAP的并发症发生率高,且对疾病严重程度和结局的影响与流感病毒相似,应给予更多关注。
研究设计与样本
- 多中心前瞻性登记研究,从中国大陆34家医院前瞻性招募住院的免疫功能正常的CAP成年患者。
- 通过分子方法检测呼吸道病毒,比较流感与非流感病毒感染组。
- 共2336例成年病毒感染者,最终915例纳入分析。
主要发现
- 流感病毒最常见(28.4%),其后为呼吸道合胞病毒(3.6%)、腺病毒(3.3%)、人冠状病毒(3.0%)、副流感病毒(2.2%)、人鼻病毒(1.8%)和人偏肺病毒(1.5%)。
- 非流感病毒感染占病毒性肺炎27.4%。
- 腺病毒感染患者实变更常见。
- 流感组与非流感组住院期间脓毒症发生率(40.1% vs 39.6%;p=0.890)和低氧血症发生率(40.1% vs 37.2%;p=0.449)无差异。
关键数值与推荐
- 非流感病毒 vs 流感病毒的多变量校正OR:CURB-65≥3为0.87(95%CI 0.26-2.84)。
- 非流感病毒 vs 流感病毒的PaO2/FiO2<200 mmHg的OR为0.72(95%CI 0.26-1.98)。
- 非流感病毒 vs 流感病毒的脓毒症OR为1.00(95%CI 0.63-1.58),低氧血症OR为1.05(95%CI 0.66-1.65)。
- 非流感病毒 vs 流感病毒的90天死亡风险比为0.51(95%CI 0.13-1.91)。
临床怎么用
- 对CAP患者应重视非流感呼吸道病毒的检测与评估。
- 非流感病毒性CAP的并发症风险与流感病毒性CAP相当,临床管理不应忽视。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Although broad knowledge of influenza viral pneumonia has been established, the significance of non-influenza respiratory viruses in community-acquired pneumonia (CAP) and their impact on clinical outcomes remains unclear, especially in the non-immunocompromised adult population.Hospitalised immunocompetent patients with CAP were prospectively recruited from 34 hospitals in mainland China. Respiratory viruses were detected by molecular methods. Comparisons were conducted between influenza and non-influenza viral infection groups.In total, 915 out of 2336 adult patients with viral infection were enrolled in the analysis, with influenza virus (28.4%) the most frequently detected virus, followed by respiratory syncytial virus (3.6%), adenovirus (3.3%), human coronavirus (3.0%), parainfluenza virus (2.2%), human rhinovirus (1.8%) and human metapneumovirus (1.5%). Non-influenza viral infections accounted for 27.4% of viral pneumonia. Consolidation was more frequently observed in patients with adenovirus infection. The occurrence of complications such as sepsis (40.1% versus 39.6%; p=0.890) and hypoxaemia (40.1% versus 37.2%; p=0.449) during hospitalisation in the influenza viral infection group did not differ from that of the non-influenza viral infection group. Compared with influenza virus infection, the multivariable adjusted odds ratios of CURB-65 (confusion, urea >7 mmol·L-1, respiratory rate ≥30 breaths·min-1, blood pressure <90 mmHg (systolic) or ≤60 mmHg (diastolic), age ≥65 years) ≥3, arterial oxygen tension/inspiratory oxygen fraction <200 mmHg, and occurrence of sepsis and hypoxaemia for non-influenza respiratory virus infection were 0.87 (95% CI 0.26-2.84), 0.72 (95% CI 0.26-1.98), 1.00 (95% CI 0.63-1.58) and 1.05 (95% CI 0.66-1.65), respectively. The hazard ratio of 90-day mortality was 0.51 (95% CI 0.13-1.91).The high incidence of complications in non-influenza viral pneumonia and similar impact of non-influenza respiratory viruses relative to influenza virus on disease severity and outcomes suggest more attention should be given to CAP caused by non-influenza respiratory viruses.
引用
- Zhou F, Wang Y, Liu Y, et al. Disease severity and clinical outcomes of community-acquired pneumonia caused by non-influenza respiratory viruses in adults: a multicentre prospective registry study from the CAP-China Network. Eur Respir J. 2019. PMID: 31164430. doi:10.1183/13993003.02406-2018
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。